MINI REVIEW article
Sec. Integrative Physiology
Volume 5 - 2014 | https://doi.org/10.3389/fphys.2014.00480
Hormonal regulation of the hypothalamic melanocortin system
- 1Departments of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA
- 2Program in Cell Signaling and Neurobiology of Metabolism, Yale University School of Medicine, New Haven, CT, USA
- 3Department of Neurobiology, Yale University School of Medicine, New Haven, CT, USA
- 4Section of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA
Regulation of energy homeostasis is fundamental for life. In animal species and humans, the Central Nervous System (CNS) plays a critical role in such regulation by integrating peripheral signals and modulating behavior and the activity of peripheral organs. A precise interplay between CNS and peripheral signals is necessary for the regulation of food intake and energy expenditure in the maintenance of energy balance. Within the CNS, the hypothalamus is a critical center for monitoring, processing and responding to peripheral signals, including hormones such as ghrelin, leptin, and insulin. Once in the brain, peripheral signals regulate neuronal systems involved in the modulation of energy homeostasis. The main hypothalamic neuronal circuit in the regulation of energy metabolism is the melanocortin system. This review will give a summary of the most recent discoveries on the hormonal regulation of the hypothalamic melanocortin system in the control of energy homeostasis.
Hypothalamic Melanocortin System
Energy homeostasis is a tightly regulated process and the imbalance between its components, food intake and energy expenditure, causes metabolic dysfunctions including obesity, a major risk factor for comorbidities including type 2 diabetes, hypertension and stroke, and cardiovascular diseases. A major player in the regulation of energy homeostasis is the Central Nervous System (CNS) and specifically the hypothalamus. By monitoring, processing and responding to peripheral signals, such as hormones, the hypothalamus in turn will regulate peripheral organ functions. Within the hypothalamus several neuronal populations have been identified as important players in metabolism regulation. The central melanocortin system consists of three neuronal populations: the pro-opiomelanocortin (POMC)-expressing neurons, the neuropeptide Y (NPY) and agouti-related peptide (AgRP)-co-expressing neurons (Cowley et al., 1999; Elmquist et al., 1999) located in the hypothalamic arcuate nucleus and the melanocortin 4 receptor (MC4R)-expressing neurons located in the hypothalamic paraventricular nucleus. While the anorexigenic POMC neurons, by activating MC4R neurons, induce decreased food intake and increased energy expenditure, the orexigenic NPY/AgRP neurons, by antagonizing POMC action on MC4R, increase food intake and decrease energy expenditure, thus increasing body weight.
The POMC gene encodes a protein precursor that generates a number of bioactive peptides, including adrenocorticotrophin (ACTH), α-, β-, and γ-melanocyte stimulating hormone (α-MSH, β-MSH, and γ-MSH) and β-endorphin, via several post-translational modification processes. Among these peptides, α-MSH is the most well-known anorexigenic peptide which mediates the effects on food intake and energy expenditure through its binding and activation of MCRs (Ollmann et al., 1997).
The critical role of POMC in the regulation of metabolism has been evidenced by studies showing that in humans, individuals with POMC gene mutations display early-onset obesity (Krude et al., 1998; Krude and Gruters, 2000). A similar obese phenotype occurs also in POMC-deficient mice (Yaswen et al., 1999). However, while the acute ablation of POMC neurons in adult mice results in an obese phenotype with hyperphagia (Gropp et al., 2005), postnatal ablation of POMC neurons leads to an obese phenotype with reduced energy expenditure but no hyperphagia (Greenman et al., 2013). On the other hand, reactivation of central POMC at different stages of development in neural-specific POMC deficient mice reduces food intake and weight gain and attenuates comorbidities such as hyperglycemia and hyperinsulinemia (Bumaschny et al., 2012).
Contrary to POMC mutations, NPY, and AgRP gene mutations produce a negligible phenotype with no difference in food intake and body weight (Erickson et al., 1996; Qian et al., 2002; Gropp et al., 2005; Luquet et al., 2005), suggesting that compensatory mechanisms may occur during development (Wu and Palmiter, 2011). Indeed, with the use of the diphtheria toxin and diphtheria toxin receptor (DTR)-mediated cell specific knockout system (Saito et al., 2001), acute ablation of AgRP neurons in adult mice causes a significant metabolic effect (Gropp et al., 2005; Luquet et al., 2005). Because these neurons also produce and release the inhibitory amino acid neurotransmitter, γ-aminobutyric acid (GABA), its role in the development of this metabolic phenotype regulation has been postulated. Indeed, AgRP-specific vesicular GABA transporter knockout mice have a lean phenotype and are resistant to high fat diet-induced obesity (Tong et al., 2008). GABAergic signaling by NPY/AgRP neurons inhibits POMC neurons in the ARC by direct synaptic innervations (Horvath et al., 1997; Cowley et al., 2001) and also inhibits the parabrachial nucleus (PBN) in the hindbrain (Wu et al., 2009). Moreover, the direct delivery of bretazenil (a GABA receptor partial agonist) into the PBN prevented anorexia caused by AgRP neuronal ablation, suggesting that GABAergic signaling in the PBN is important for the regulation of feeding (Wu et al., 2009).
Recently, advanced technologies such as the optogenetic and DREADD (designer receptors exclusively activated by designer drugs) systems have provided stronger evidences on the central role of POMC and NPY/AgRP neurons in the regulation of feeding behavior (Aponte et al., 2011; Krashes et al., 2011, 2013; Atasoy et al., 2012; Zhan et al., 2013). For example, Zhan and collaborators recently showed that POMC neurons regulate feeding by integrating long-term information from the ARC and short-term information from the NTS in the brainstem (Zhan et al., 2013). On the other hand, activation of AgRP neurons acutely promotes feeding behavior but suppression of POMC neurons is not required for this acute effect (Aponte et al., 2011; Krashes et al., 2011; Atasoy et al., 2012). One study, using DREADD system, has addressed the temporal effect of the acute activation of AgRP neurons on food intake in single, double or triple knockdown of NPY, AgRP-specific vesicular GABA transporter and MC4R (Krashes et al., 2013). This study proposes that NPY and GABA are required for the short-term feeding response while AgRP is responsible for the long-term feeding response.
α-MSH and AgRP exert their metabolic effects through direct interaction with MCRs. In the CNS, MC3R, expressed in the hypothalamic arcuate POMC nucleus, and MC4R, expressed in several brain areas including the paraventricular nucleus of the hypothalamus, play a critical role in mediating the agonistic and antagonistic effect of α-MSH and AgRP, respectively (Ollmann et al., 1997). Both MC3R and MC4R deficient mice displayed an obese phenotype, however, while MC3R are not hyperphagic (Butler et al., 2000; Chen et al., 2000; Renquist et al., 2012), MC4R deficiency mice show hyperphagia and reduced energy expenditure (Huszar et al., 1997; Marsh et al., 1999; Butler et al., 2001). In addition, mutations in the human MC4R gene are associated with non-syndromic obesity (Vaisse et al., 1998; Yeo et al., 1998).
The importance of MC4R-expressing neurons in the PVN in regulating metabolism has been recently showed by studies in which restoration of MC4Rs in PVN Single-minded 1 (SIM1) neurons of MC4Rs deficient mice induced a reduced obese phenotype (Xu et al., 2013; Shah et al., 2014). Of note, SIM1 seems to play also an important role in metabolism regulation both in humans and mice (Holder et al., 2000; Michaud et al., 2001).
The activity of the melanocortin neurons is regulated by many peripheral signals including hormones such as leptin, ghrelin, insulin, glucocorticoids, and thyroid hormones. By either activating or inhibiting these neurons, these peripheral signals convey information on the metabolic status of the organism.
Leptin is an anorexigenic hormone produced and released by the white adipose tissue in the amount proportional to the mass of fat in the body (Zhang et al., 1994; Frederich et al., 1995; Maffei et al., 1995). Leptin interacts with six types of receptors (Ob-Ra, -Rb, -Rc, Rd, Re, and Rf) encoded by a single leptin receptor gene (Ob-R) (Lee et al., 1996; Wang et al., 1996). However, only the long form of leptin receptors (Ob-Rb), consisting of an extracellular and an intact cytoplasmic domain, mediates the anorexigenic effect of leptin (De Luca et al., 2005). Deficiency in leptin or leptin receptors induces a morbid obese phenotype characterized by hyperphagia, hyperglycemia, hyperlipidemia, and reduced energy expenditure in both rodents and humans (Halaas et al., 1995; Chen et al., 1996; Montague et al., 1997; Clement et al., 1998). Neuron-specific Ob-R-deficient (db/db) mice displayed an obese phenotype while hepatocyte-specific db/db mice are normal (Cohen et al., 2001; De Luca et al., 2005), suggesting that the direct effect of leptin in the brain is essential for metabolism regulation. Mice lacking Ob-Rb in POMC neurons, AgRP neurons or both POMC/AgRP neurons displayed increased body weight and fat mass (Balthasar et al., 2004; Van De Wall et al., 2008), although their phenotypes are milder compared to those of whole brain neuron-specific Ob-Rb deficient mice, suggesting the involvement of other leptin receptor-expressing neurons in mediating the effect of leptin on energy homeostasis.
Leptin regulates POMC and NPY/AgRP neurons at different levels. For examples, leptin increases POMC mRNA levels while decreasing NPY/AgRP mRNAs (Mizuno et al., 1998; Mizuno and Mobbs, 1999). Besides the transcriptional regulation, leptin directly depolarizes (activates) POMC neurons while simultaneously hyperpolarizing (inactivates) NPY/AgRP neurons (Cowley et al., 2001). In addition, systemic leptin administration to leptin deficient (ob/ob) mice rapidly induced synaptic input reorganization onto NPY/AgRP and POMC neurons (Pinto et al., 2004), suggesting that the synaptic rearrangement is an important event for leptin-induced behavioral changes (Horvath, 2006). A recent study demonstrated that AgRP neurons are critical in mediating metabolic syndrome in ob/ob mice since ablation of Agrp neurons in leptin deficient (ob/ob) mice showed reduced food intake and improved glucose tolerance (Wu et al., 2012).
Insulin, produced from pancreatic β-cells, plays a fundamental role in the regulation of glucose homeostasis by modulating glucose uptake in peripheral organs (Bagdade et al., 1967). However, since insulin receptors (IR) are widely expressed in the brain (Havrankova et al., 1978), accumulated evidences have indicated a role for insulin in the CNS. Indeed, brain specific-IR deficient mice develop obesity with increased body weight, fat mass, and food intake (Bruning et al., 2000). However, mice with selective deletion of IR in the arcuate melanocortin system, either POMC or AgRP neurons, did not display alteration in energy homeostasis, while only a defective suppression on hepatic glucose production was found in mice with selective deletion of IR in AgRP neurons (Konner et al., 2007). In addition, re-expression of IR in either POMC or AgRP neurons of L1 mice, a genetic mouse model with significant reduction of IR in the ARC (Okamoto et al., 2004), suggested that insulin signaling in AgRP neurons negatively regulates hepatic glucose production while IR activation in POMC neurons positively regulates hepatic glucose production and energy expenditure (Lin et al., 2010). Interestingly, when both leptin and IR were ablated in POMC neurons, systemic insulin resistance despite increased pancreatic insulin secretion was observed in these mice (Hill et al., 2010). In addition, the obese phenotype observed in POMC-specific ObR knockout mice was ameliorated when both ObR and IR were selectively deleted from POMC neurons, suggesting that insulin and leptin signaling in POMC neurons may have opposing effects in the regulation of body weight but additive effects on glucose homeostasis. In support of this, leptin and insulin responsive neurons are expressed in distinct subpopulations of POMC neurons (Williams et al., 2010). Thus, the divergent effects of leptin and insulin on energy homeostasis may due to the activation of different POMC subpopulations.
Ghrelin, the hunger hormone, is predominantly secreted by specialized endocrine cells of the stomach when the stomach is empty. Ghrelin is synthesized as a preprohormone and several processes are required to generate its active form. After removing the signal peptide from the preprohormone, ghrelin precursor is acylated at the third serine with n-octanoic acid by an enzyme called ghrelin o-acyltransferase (GOAT) (Gutierrez et al., 2008; Yang et al., 2008) and then it is cleaved by prohormone convertase 1/3 to produce the active 28-amino-acid acylated ghrelin (Zhu et al., 2006). Ghrelin exerts its orexigenic effects through the growth hormone secretagogue receptor (GHSR) (Sun et al., 2004). The physiological function of Ghrelin and GHSR on feeding has been demonstrated by ghrelin and GHSR deficient mice. Both ghrelin- and GHSR-deficient mice are resistant to high-fat diet-induced obesity but only when mice are exposed to the diet shortly after post-weaning and not in adulthood (Sun et al., 2003; Wortley et al., 2004, 2005; Zigman et al., 2005).
The strongest expression of GHSR has been observed in the hypothalamus (Willesen et al., 1999). This observation, together with ghrelin-induced high c-fos expression in the hypothalamus, indicated this site of the CNS as main site of ghrelin's action. In the ARC, GHSR is predominantly expressed in NPY/AgRP neurons. Accordingly, peripheral and central administration of ghrelin induced c-fos expression in NPY/AgRP neurons (Nakazato et al., 2001; Wang et al., 2002). In addition, ghrelin increases NPY and AgRP mRNA expression levels and the electrical activity of NPY/AgRP neurons (Kamegai et al., 2001; Shintani et al., 2001; Cowley et al., 2003; Seoane et al., 2003; Van Den Top et al., 2004). Although ghrelin inhibits POMC neuronal activity, no GHSR expression has been reported in POMC neurons (Willesen et al., 1999) thus suggesting that this inhibitory effect may be mediated by the activation of NPY/AgRP neurons. In addition, ghrelin positively regulates prolyl carboxypeptidase, the enzyme responsible for α-MSH degradation (Kwon Jeong et al., 2013) thus further increasing the orexigenic tone. Ghrelin-induced food intake is mediated by NPY/AgRP neurons (Nakazato et al., 2001; Shintani et al., 2001; Chen et al., 2004). For example, administration of neutralizing antibodies or antagonists of both NPY and AgRP blunted the orexigenic effects of ghrelin. Consistently, ghrelin's effect on feeding is abolished in NPY/AgRP double-deficient mice (Chen et al., 2004). NPY/AgRP neurons-mediated ghrelin's effect is evident in diet-induced obese mice (DIO). DIO mice show decreased expression of Npy and AgRP mRNA levels, decreased Goat mRNA levels in the stomach and decreased hypothalamic GHSR expression and they are ghrelin resistance (Briggs et al., 2010). Interestingly, while ghrelin resistance has been observed in DIO mice, ob/ob mice retain their sensitivity to ghrelin, suggesting that elevated leptin levels may be involved in the development of ghrelin resistance. In support of this, a recent study showed that central leptin administration in ob/ob mice induced ghrelin resistance (Briggs et al., 2014). AgRP-selective re-expression of GHSR in whole body of GHSR-deficient mice partially restores the orexigenic response to ghrelin (Wang et al., 2014). In addition, AgRP-specific vesicular GABA transporter knockout mice showed impaired ghrelin-mediated feeding response and impaired inhibitory postsynaptic potentials in POMC neurons, indicating that GABA release from AgRP neurons is an important mediator of ghrelin's effect on food intake (Tong et al., 2008). Of note, uncoupling protein 2 (UCP2) is a mediator of ghrelin's action on feeding behavior in both the hypothalamus and the ventrotegmental area (VTA). In Ucp2 deficient mice, intrahypothalamic administration of ghrelin showed a blunted effect on food intake and intra-VTA ghrelin injection also attenuated food intake (Andrews et al., 2008).
Thyroid hormones play an important role in metabolism regulation affecting nearly all the tissues in the body. Thyroxine (T4) produced by the thyroid gland is converted in target tissues in the active form of thyroid hormone, Triiodothyronine (T3), by a process called 5′ deiodination. Thyroid hormones affect metabolism acting on both food intake and energy expenditure (Vijayan and Mccann, 1977; Suzuki et al., 1982; Lin et al., 1983; Choi et al., 2002; Herwig et al., 2008; Klieverik et al., 2009). The hyperphagia, induced by increased thyroid hormones levels, is mediated by the CNS. Indeed, central T3 administration induced increased food intake by increasing and reducing NPY and POMC mRNA levels, respectively (Ishii et al., 2003). Changes in central T3 levels occur during different metabolic states (Van Haasteren et al., 1995). For example, elevated levels of T3 occur in the hypothalamus during starvation (Coppola et al., 2005, 2007). This increased T3 is due to the elevated activity of the enzyme responsible for the conversion of T4 in T3 (Diano et al., 1998). Similar to the effect of T3 in the brown adipose tissue in increasing uncoupling protein 1 (UCP1) activity, T3 in the hypothalamus regulates UCP2 levels, which in turn, will affect the activity of NPY/AgRP neurons and thus increase food intake. Via this signaling pathway involving NPY/AgRP neuronal activity, T3 is also responsible for fasting-induced suppression of TRH mRNA expression in the PVN (Coppola et al., 2005, 2007; Vella et al., 2011).
Glucocorticoids are known regulators of energy balance (Nieuwenhuizen and Rutters, 2008). For example, Cushing' syndrome, one pathology characterized by hypercortisolism, displays several symptoms including hypertension, insulin resistance, hyperglycemia as well as rapid weight gain (Hankin et al., 1977). Conversely, Addison's disease, condition of hypocortisolism, causes weight loss (Lovas and Husebye, 2007). Similarly, hypocortisolism induced by adrenalectomy (ADX) reduces food intake, fat stores and body weight (Dallman et al., 2004). Since ACTH, which is generated from POMC-expressing cells in the pituitary gland, stimulates the production of glucocorticoids from the adrenals, pituitary POMC's effects on energy balance were addressed in neural-specific POMC deficient mice (Smart et al., 2006). Interestingly, increased glucocorticoids by re-expression of pituitary POMC in neural-specific POMC deficient mice exacerbates obesity with severe insulin resistance, suggesting that central POMC's role is not substituted by peripheral POMC (Smart et al., 2006). In further support of the role of glucocorticoids in the regulation of energy balance, many obese mouse models including diet-induced obesity and genetic mouse models were characterized by elevated corticosterone levels, and ADX to these mice has been shown to ameliorate their obese phenotype (Okada et al., 1993; Makimura et al., 2000). The mechanism by which ADX ameliorates obesity involves the CNS. For example, corticosterone has been shown to affect the hypothalamic melanocortin signaling by regulating POMC and AgRP mRNA expression in leptin-deficient mice (Makimura et al., 2000). In addition, studies from our group have shown that ADX directly influences neuronal activity of the arcuate POMC neurons by affecting the synaptic input organization of these neurons (Gyengesi et al., 2010). Furthermore, ADX has been reported to enhance leptin's effect on feeding by reducing the responsiveness of melanocortin receptors to its ligands (Drazen et al., 2003).
The hypothalamic melanocortin system is an integrative center in the regulation of energy balance. Numerous studies have shown that many peripheral signals including hormones can directly influence the activity of the hypothalamic melanocortin system. Besides hormones, other signals including nutrients such as glucose (Thorens, 2012), lipids (Lam et al., 2005; Moulle et al., 2014), and amino acids (Cota et al., 2006; Schwartz, 2013) also function as signal molecules for the melanocortin system.
All of these signals have been shown to regulate the melanocortin system via extracellular and intracellular morphological changes that will affect the activity levels of the different component of the system. These changes include synaptic input organization (Pinto et al., 2004; Zeltser et al., 2012), neuron-glia interaction, and intracellular organelles alterations including mitochondrial and peroxisomal density and function (for review see Koch and Horvath, 2014).
In conclusion, further studies on the mechanisms controlling the melanocortin system are crucial to make advancement in our abilities to develop new therapies for the treatment of metabolic disorders.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
This work was supported by NIH grants DK 097566 and we would like to thank the Science, Technology, and Research Scholars (STARS) program at Yale College.
Andrews, Z. B., Liu, Z. W., Walllingford, N., Erion, D. M., Borok, E., Friedman, J. M., et al. (2008). UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 454, 846–851. doi: 10.1038/nature07181
Bagdade, J. D., Bierman, E. L., and Porte, D. Jr. (1967). The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J. Clin. Invest. 46, 1549–1557. doi: 10.1172/JCI105646
Balthasar, N., Coppari, R., Mcminn, J., Liu, S. M., Lee, C. E., Tang, V., et al. (2004). Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42, 983–991. doi: 10.1016/j.neuron.2004.06.004
Briggs, D. I., Enriori, P. J., Lemus, M. B., Cowley, M. A., and Andrews, Z. B. (2010). Diet-induced obesity causes ghrelin resistance in arcuate NPY/AgRP neurons. Endocrinology 151, 4745–4755. doi: 10.1210/en.2010-0556
Briggs, D. I., Lockie, S. H., Benzler, J., Wu, Q., Stark, R., Reichenbach, A., et al. (2014). Evidence that diet-induced hyperleptinemia, but not hypothalamic gliosis, causes ghrelin resistance in NPY/AgRP neurons of male mice. Endocrinology 155, 2411–2422. doi: 10.1210/en.2013-1861
Bruning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., et al. (2000). Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122–2125. doi: 10.1126/science.289.5487.2122
Bumaschny, V. F., Yamashita, M., Casas-Cordero, R., Otero-Corchon, V., De Souza, F. S., Rubinstein, M., et al. (2012). Obesity-programmed mice are rescued by early genetic intervention. J. Clin. Invest. 122, 4203–4212. doi: 10.1172/JCI62543
Butler, A. A., Kesterson, R. A., Khong, K., Cullen, M. J., Pelleymounter, M. A., Dekoning, J., et al. (2000). A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518–3521. doi: 10.1210/endo.141.9.7791
Butler, A. A., Marks, D. L., Fan, W., Kuhn, C. M., Bartolome, M., and Cone, R. D. (2001). Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat. Neurosci. 4, 605–611. doi: 10.1038/88423
Chen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X. M., Yu, H., et al. (2000). Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97–102. doi: 10.1038/79254
Chen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., et al. (1996). Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84, 491–495. doi: 10.1016/S0092-8674(00)81294-5
Chen, H. Y., Trumbauer, M. E., Chen, A. S., Weingarth, D. T., Adams, J. R., Frazier, E. G., et al. (2004). Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145, 2607–2612. doi: 10.1210/en.2003-1596
Choi, Y. H., Hartzell, D., Azain, M. J., and Baile, C. A. (2002). TRH decreases food intake and increases water intake and body temperature in rats. Physiol. Behav. 77, 1–4. doi: 10.1016/S0031-9384(02)00784-9
Clement, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., et al. (1998). A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398–401. doi: 10.1038/32911
Cohen, P., Zhao, C., Cai, X., Montez, J. M., Rohani, S. C., Feinstein, P., et al. (2001). Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest. 108, 1113–1121. doi: 10.1172/JCI200113914
Coppola, A., Hughes, J., Esposito, E., Schiavo, L., Meli, R., and Diano, S. (2005). Suppression of hypothalamic deiodinase type II activity blunts TRH mRNA decline during fasting. FEBS Lett. 579, 4654–4658. doi: 10.1016/j.febslet.2005.07.035
Coppola, A., Liu, Z. W., Andrews, Z. B., Paradis, E., Roy, M. C., Friedman, J. M., et al. (2007). A central thermogenic-like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2. Cell Metab. 5, 21–33. doi: 10.1016/j.cmet.2006.12.002
Cowley, M. A., Pronchuk, N., Fan, W., Dinulescu, D. M., Colmers, W. F., and Cone, R. D. (1999). Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24, 155–163. doi: 10.1016/S0896-6273(00)80829-6
Cowley, M. A., Smart, J. L., Rubinstein, M., Cerdan, M. G., Diano, S., Horvath, T. L., et al. (2001). Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480–484. doi: 10.1038/35078085
Cowley, M. A., Smith, R. G., Diano, S., Tschop, M., Pronchuk, N., Grove, K. L., et al. (2003). The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649–661. doi: 10.1016/S0896-6273(03)00063-1
Dallman, M. F., La Fleur, S. E., Pecoraro, N. C., Gomez, F., Houshyar, H., and Akana, S. F. (2004). Minireview: glucocorticoids–food intake, abdominal obesity, and wealthy nations in 2004. Endocrinology 145, 2633–2638. doi: 10.1210/en.2004-0037
De Luca, C., Kowalski, T. J., Zhang, Y., Elmquist, J. K., Lee, C., Kilimann, M. W., et al. (2005). Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J. Clin. Invest. 115, 3484–3493. doi: 10.1172/JCI24059
Diano, S., Naftolin, F., Goglia, F., and Horvath, T. L. (1998). Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus. Endocrinology 139, 2879–2884.
Drazen, D. L., Wortman, M. D., Schwartz, M. W., Clegg, D. J., Van Dijk, G., Woods, S. C., et al. (2003). Adrenalectomy alters the sensitivity of the central nervous system melanocortin system. Diabetes 52, 2928–2934. doi: 10.2337/diabetes.52.12.2928
Frederich, R. C., Hamann, A., Anderson, S., Lollmann, B., Lowell, B. B., and Flier, J. S. (1995). Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1, 1311–1314. doi: 10.1038/nm1295-1311
Greenman, Y., Kuperman, Y., Drori, Y., Asa, S. L., Navon, I., Forkosh, O., et al. (2013). Postnatal ablation of POMC neurons induces an obese phenotype characterized by decreased food intake and enhanced anxiety-like behavior. Mol. Endocrinol. 27, 1091–1102. doi: 10.1210/me.2012-1344
Gropp, E., Shanabrough, M., Borok, E., Xu, A. W., Janoschek, R., Buch, T., et al. (2005). Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 8, 1289–1291. doi: 10.1038/nn1548
Gutierrez, J. A., Solenberg, P. J., Perkins, D. R., Willency, J. A., Knierman, M. D., Jin, Z., et al. (2008). Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. U.S.A. 105, 6320–6325. doi: 10.1073/pnas.0800708105
Gyengesi, E., Liu, Z. W., D'agostino, G., Gan, G., Horvath, T. L., Gao, X. B., et al. (2010). Corticosterone regulates synaptic input organization of POMC and NPY/AgRP neurons in adult mice. Endocrinology 151, 5395–5402. doi: 10.1210/en.2010-0681
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., et al. (1995). Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543–546. doi: 10.1126/science.7624777
Hankin, M. E., Theile, H. M., and Steinbeck, A. W. (1977). An evaluation of laboratory tests for the detection and differential diagnosis of Cushing's syndrome. Clin. Endocrinol. 6, 185–196. doi: 10.1111/j.1365-2265.1977.tb03314.x
Hill, J. W., Elias, C. F., Fukuda, M., Williams, K. W., Berglund, E. D., Holland, W. L., et al. (2010). Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab. 11, 286–297. doi: 10.1016/j.cmet.2010.03.002
Horvath, T. L., Bechmann, I., Naftolin, F., Kalra, S. P., and Leranth, C. (1997). Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations. Brain Res. 756, 283–286. doi: 10.1016/S0006-8993(97)00184-4
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., et al. (1997). Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131–141. doi: 10.1016/S0092-8674(00)81865-6
Ishii, S., Kamegai, J., Tamura, H., Shimizu, T., Sugihara, H., and Oikawa, S. (2003). Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis. Neuroendocrinology 78, 321–330. doi: 10.1159/000074885
Kamegai, J., Tamura, H., Shimizu, T., Ishii, S., Sugihara, H., and Wakabayashi, I. (2001). Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 50, 2438–2443. doi: 10.2337/diabetes.50.11.2438
Klieverik, L. P., Coomans, C. P., Endert, E., Sauerwein, H. P., Havekes, L. M., Voshol, P. J., et al. (2009). Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo. Endocrinology 150, 5639–5648. doi: 10.1210/en.2009-0297
Koch, M., and Horvath, T. L. (2014). Molecular and cellular regulation of hypothalamic melanocortin neurons controlling food intake and energy metabolism. Mol. Psychiatry 19, 752–761. doi: 10.1038/mp.2014.30
Konner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., et al. (2007). Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab. 5, 438–449. doi: 10.1016/j.cmet.2007.05.004
Krashes, M. J., Koda, S., Ye, C., Rogan, S. C., Adams, A. C., Cusher, D. S., et al. (2011). Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J. Clin. Invest. 121, 1424–1428. doi: 10.1172/JCI46229
Krashes, M. J., Shah, B. P., Koda, S., and Lowell, B. B. (2013). Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP. Cell Metab. 18, 588–595. doi: 10.1016/j.cmet.2013.09.009
Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., and Gruters, A. (1998). Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155–157. doi: 10.1038/509
Krude, H., and Gruters, A. (2000). Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol. Metab. 11, 15–22. doi: 10.1016/S1043-2760(99)00213-1
Lee, G. H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., et al. (1996). Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632–635. doi: 10.1038/379632a0
Lin, H. V., Plum, L., Ono, H., Gutierrez-Juarez, R., Shanabrough, M., Borok, E., et al. (2010). Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes 59, 337–346. doi: 10.2337/db09-1303
Luquet, S., Perez, F. A., Hnasko, T. S., and Palmiter, R. D. (2005). NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 310, 683–685. doi: 10.1126/science.1115524
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., et al. (1995). Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155–1161. doi: 10.1038/nm1195-1155
Makimura, H., Mizuno, T. M., Roberts, J., Silverstein, J., Beasley, J., and Mobbs, C. V. (2000). Adrenalectomy reverses obese phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice. Diabetes 49, 1917–1923. doi: 10.2337/diabetes.49.11.1917
Marsh, D. J., Hollopeter, G., Huszar, D., Laufer, R., Yagaloff, K. A., Fisher, S. L., et al. (1999). Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat. Genet. 21, 119–122. doi: 10.1038/5070
Michaud, J. L., Boucher, F., Melnyk, A., Gauthier, F., Goshu, E., Levy, E., et al. (2001). Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum. Mol. Genet. 10, 1465–1473. doi: 10.1093/hmg/10.14.1465
Mizuno, T. M., Kleopoulos, S. P., Bergen, H. T., Roberts, J. L., Priest, C. A., and Mobbs, C. V. (1998). Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47, 294–297. doi: 10.2337/diab.47.2.294
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., et al. (1997). Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903–908. doi: 10.1038/43185
Okada, S., Onai, T., Kilroy, G., York, D. A., and Bray, G. A. (1993). Adrenalectomy of the obese Zucker rat: effects on the feeding response to enterostatin and specific mRNA levels. Am. J. Physiol. 265, R21–R27.
Ollmann, M. M., Wilson, B. D., Yang, Y. K., Kerns, J. A., Chen, Y., Gantz, I., et al. (1997). Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135–138. doi: 10.1126/science.278.5335.135
Pinto, S., Roseberry, A. G., Liu, H., Diano, S., Shanabrough, M., Cai, X., et al. (2004). Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304, 110–115. doi: 10.1126/science.1089459
Qian, S., Chen, H., Weingarth, D., Trumbauer, M. E., Novi, D. E., Guan, X., et al. (2002). Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol. Cell. Biol. 22, 5027–5035. doi: 10.1128/MCB.22.14.5027-5035.2002
Renquist, B. J., Murphy, J. G., Larson, E. A., Olsen, D., Klein, R. F., Ellacott, K. L., et al. (2012). Melanocortin-3 receptor regulates the normal fasting response. Proc. Natl. Acad. Sci. U.S.A. 109, E1489–E1498. doi: 10.1073/pnas.1201994109
Saito, M., Iwawaki, T., Taya, C., Yonekawa, H., Noda, M., Inui, Y., et al. (2001). Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat. Biotechnol. 19, 746–750. doi: 10.1038/90795
Seoane, L. M., Lopez, M., Tovar, S., Casanueva, F. F., Senaris, R., and Dieguez, C. (2003). Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144, 544–551. doi: 10.1210/en.2002-220795
Shah, B. P., Vong, L., Olson, D. P., Koda, S., Krashes, M. J., Ye, C., et al. (2014). MC4R-expressing glutamatergic neurons in the paraventricular hypothalamus regulate feeding and are synaptically connected to the parabrachial nucleus. Proc. Natl. Acad. Sci. U.S.A. 111, 13193–13198. doi: 10.1073/pnas.1407843111
Shintani, M., Ogawa, Y., Ebihara, K., Aizawa-Abe, M., Miyanaga, F., Takaya, K., et al. (2001). Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50, 227–232. doi: 10.2337/diabetes.50.2.227
Smart, J. L., Tolle, V., and Low, M. J. (2006). Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice. J. Clin. Invest. 116, 495–505. doi: 10.1172/JCI25243
Sun, Y., Wang, P., Zheng, H., and Smith, R. G. (2004). Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. U.S.A. 101, 4679–4684. doi: 10.1073/pnas.0305930101
Suzuki, T., Kohno, H., Sakurada, T., Tadano, T., and Kisara, K. (1982). Intracranial injection of thyrotropin releasing hormone (TRH) suppresses starvation-induced feeding and drinking in rats. Pharmacol. Biochem. Behav. 17, 249–253. doi: 10.1016/0091-3057(82)90078-8
Tong, Q., Ye, C. P., Jones, J. E., Elmquist, J. K., and Lowell, B. B. (2008). Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat. Neurosci. 11, 998–1000. doi: 10.1038/nn.2167
Van Den Top, M., Lee, K., Whyment, A. D., Blanks, A. M., and Spanswick, D. (2004). Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat. Neurosci. 7, 493–494. doi: 10.1038/nn1226
Van De Wall, E., Leshan, R., Xu, A. W., Balthasar, N., Coppari, R., Liu, S. M., et al. (2008). Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology 149, 1773–1785. doi: 10.1210/en.2007-1132
Van Haasteren, G. A., Linkels, E., Klootwijk, W., Van Toor, H., Rondeel, J. M., Themmen, A. P., et al. (1995). Starvation-induced changes in the hypothalamic content of prothyrotrophin-releasing hormone (proTRH) mRNA and the hypothalamic release of proTRH-derived peptides: role of the adrenal gland. J. Endocrinol. 145, 143–153. doi: 10.1677/joe.0.1450143
Vella, K. R., Ramadoss, P., Lam, F. S., Harris, J. C., Ye, F. D., Same, P. D., et al. (2011). NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways. Cell Metab. 14, 780–790. doi: 10.1016/j.cmet.2011.10.009
Vijayan, E., and Mccann, S. M. (1977). Suppression of feeding and drinking activity in rats following intraventricular injection of thyrotropin releasing hormone (TRH). Endocrinology 100, 1727–1730. doi: 10.1210/endo-100-6-1727
Wang, L., Saint-Pierre, D. H., and Tache, Y. (2002). Peripheral ghrelin selectively increases Fos expression in neuropeptide Y - synthesizing neurons in mouse hypothalamic arcuate nucleus. Neurosci. Lett. 325, 47–51. doi: 10.1016/S0304-3940(02)00241-0
Wang, Q., Liu, C., Uchida, A., Chuang, J. C., Walker, A., Liu, T., et al. (2014). Arcuate AgRP neurons mediate orexigenic and glucoregulatory actions of ghrelin. Mol. Metab. 3, 64–72. doi: 10.1016/j.molmet.2013.10.001
Willesen, M. G., Kristensen, P., and Romer, J. (1999). Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70, 306–316. doi: 10.1159/000054491
Williams, K. W., Margatho, L. O., Lee, C. E., Choi, M., Lee, S., Scott, M. M., et al. (2010). Segregation of acute leptin and insulin effects in distinct populations of arcuate proopiomelanocortin neurons. J. Neurosci. 30, 2472–2479. doi: 10.1523/JNEUROSCI.3118-09.2010
Wortley, K. E., Anderson, K. D., Garcia, K., Murray, J. D., Malinova, L., Liu, R., et al. (2004). Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc. Natl. Acad. Sci. U.S.A. 101, 8227–8232. doi: 10.1073/pnas.0402763101
Wortley, K. E., Del Rincon, J. P., Murray, J. D., Garcia, K., Iida, K., Thorner, M. O., et al. (2005). Absence of ghrelin protects against early-onset obesity. J. Clin. Invest. 115, 3573–3578. doi: 10.1172/JCI26003
Wu, Q., Whiddon, B. B., and Palmiter, R. D. (2012). Ablation of neurons expressing agouti-related protein, but not melanin concentrating hormone, in leptin-deficient mice restores metabolic functions and fertility. Proc. Natl. Acad. Sci. U.S.A. 109, 3155–3160. doi: 10.1073/pnas.1120501109
Xu, Y., Wu, Z., Sun, H., Zhu, Y., Kim, E. R., Lowell, B. B., et al. (2013). Glutamate mediates the function of melanocortin receptor 4 on Sim1 neurons in body weight regulation. Cell Metab. 18, 860–870. doi: 10.1016/j.cmet.2013.11.003
Yang, J., Brown, M. S., Liang, G., Grishin, N. V., and Goldstein, J. L. (2008). Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387–396. doi: 10.1016/j.cell.2008.01.017
Yaswen, L., Diehl, N., Brennan, M. B., and Hochgeschwender, U. (1999). Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat. Med. 5, 1066–1070. doi: 10.1038/12506
Yeo, G. S., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, R. G., and O'rahilly, S. (1998). A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20, 111–112. doi: 10.1038/2404
Zhan, C., Zhou, J., Feng, Q., Zhang, J. E., Lin, S., Bao, J., et al. (2013). Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively. J. Neurosci. 33, 3624–3632. doi: 10.1523/JNEUROSCI.2742-12.2013
Zigman, J. M., Nakano, Y., Coppari, R., Balthasar, N., Marcus, J. N., Lee, C. E., et al. (2005). Mice lacking ghrelin receptors resist the development of diet-induced obesity. J. Clin. Invest. 115, 3564–3572. doi: 10.1172/JCI26002
Keywords: hypothalamic melanocortin system, arcuate nucleus, pro-opiomelanocortin (POMC), neuropeptide Y (NPY), agouti-related peptide (AgRP), hormones, obesity
Citation: Kim JD, Leyva S and Diano S (2014) Hormonal regulation of the hypothalamic melanocortin system. Front. Physiol. 5:480. doi: 10.3389/fphys.2014.00480
Received: 03 October 2014; Accepted: 24 November 2014;
Published online: 09 December 2014.
Edited by:Antonia Lanni, Second University of Naples, Italy
Reviewed by:Ursula H. Winzer-Serhan, Texas A&M Health Science Center, USA
Virginie Tolle, Institut National de la Santé et de la Recherche Médicale, France
Copyright © 2014 Kim, Leyva and Diano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Sabrina Diano, Departments of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, FMB 302A/333 Cedar Street, PO Box 208063, New Haven, CT 06520-208063, USA e-mail: email@example.com